Decision on the AstraZeneca vaccine before the end of the year under one condition

AstraZeneca CEO, Pascal Sorio, said he should know whether their experimental vaccine will protect people from covid 19 till the end of 2020, if trials continue

Source: Tanjug
Foto: depositphotos/bezikus
Foto: depositphotos/bezikus

AstraZeneca suspended the trials after one participant in the study allegedly contracted transverse myelitis, Reuters reported.

Speaking about the vaccine, which the World Health Organization (WHO) considers the most promising in the fight against coronavirus, Sorio said that the testing of vaccines is very often suspended, but that the difference is that the whole world is now watching what is happening.

The CEO of AstraZeneca said that the company did not know about the diagnosis of the volunteers in the examination, and added that it was not clear whether he had transverse myelitis, as well as that additional tests needed to be performed.

Sorio said the diagnosis would be handed over to an independent safety commission which would then tell the company if the tests could be continued.


Warning to Turkey: All options are on the table

EC President Charles Michel warned that all "options remain on the table" in defense of EU interests, if Turkey is not constructive about the Mediterranean Sea.

World Wednesday, September 30, 2020 09:36 Comments: 9

Peace talks rejected!

Leaders of Azerbaijan and Armenia rejected the proposal for peace talks, accusing each other of obstructing negotiations on the territory of Nagorno-Karabakh

World Wednesday, September 30, 2020 09:30 Comments: 5
page 1 of 14 go to page